Blar i Tidsskrift- og avisartikler. HV på tidsskrift "Research and Practice in Thrombosis and Haemostasis"
Viser treff 1-2 av 2
-
Fatigue after initiating rivaroxaban for venous thromboembolism
(Peer reviewed; Journal article, 2020-03-09)Background Rivaroxaban was the first new oral anticoagulant approved for treatment of venous thromboembolism (VTE). Clinical trials have shown that rivaroxaban is noninferior to conventional anticoagulation for VTE in ... -
Fatigue after initiating rivaroxaban for venous thromboembolism
(Peer reviewed; Journal article, 2020-03-09)Background. Rivaroxaban was the first new oral anticoagulant approved for treatment of venous thromboembolism (VTE). Clinical trials have shown that rivaroxaban is noninferior to conventional anticoagulation for VTE in ...